Atopy, helminths, and cancer

Medical Hypotheses

Volumn 60, Issue 1, 2003, Pages 1-5

  Zacharia, Brad ^a   Sherman, Paul ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; IMMUNOGLOBULIN E;

ARTICLE; ASCARIS LUMBRICOIDES; ATOPY; BLADDER CARCINOMA; HELMINTH; HUMAN; NONHUMAN; PRIORITY JOURNAL; TROPICS;

VERMES;

EID: 0037220065     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(02)00217-7     Document Type: Article

References (59)

1. Barnes K. C., Armelagos G. J., Morreale S. C. Darwinian medicine and the emergence of allergy. In: W. R. Trevathan, E. O. Smith, J. J. McKenna (eds). Evolutionary Medicine. Oxford; 1999. p. 209-242.
2. Seaton A., Godden D. J., Brown K. Increase in asthma: A more toxic environment or a more susceptible population? Thorax 1994; 49: 171-174.
3. Yazdanbakhsh M., Kremsner P. O., van Ree R. Allergy, parasites, the hygiene hypothesis. Science 2002; 296: 490-494.
4. Knopf P. M. Immunomodulation and allergy. Allerg Asthma Proc 2000; 21: 215-220.
5. Nesse R. M. and Williams, G. C. Why We Get Sick: The New Science of Darwinian Medicine. 1994.
6. Profet M. The function of allergy: Immunological defense against toxins. Q Rev Biol 1991; 66: 23-62.
7. Varner A. E. The increase in allergic respiratory diseases: Survival of the fittest? Chest 2002; 121: 1308-1316.
8. Matricardi P. M., Rosmini F., Riondino S., Fortini M., Ferrigno L., Rapicetta M., Bonini S. Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: Epidemiological study. Br Med J 2000; 320: 412-417.
9. Corry D. B., Kheradmand F. Induction and regulation of the IgE response. Nature 1999; 402: B18-B23.
10. Cookson W. The alliance of genes and environment in asthma and allergy. Nature 1999; 402:B5-B11.
11. Burr M. L., St Leger A. S., Bevan C., Merrett T. G. A community survey of asthmatic characteristics. Thorax 1975; 30: 663-668.
12. Berciano F. A., Crespo M., Bao C. G., Alvarez F. V. Serum levels of total IgE in non-allergic children. Influence of genetic and environmental factors. Allergy 1987; 42: 276-283.
13. Bennett F., Lawrence A. W. W., Campbell M., Rawlins S. C. Year-round total serum IgE and IgG4 levels in allergic and non-allergic West Indian medical students. WI Med J 1987; 36: 177-180.
14. Burrows B., Martinez F. D., Halonen M., Barbee R. A., Cline M. G. Association of asthma with serum IgE levels and skin-test reactivity to allergens. New Eng J Med 1989; 320: 271-276.
15. H2 clones. J Immunol 1990; 144: 2031-2037.
16. Husz S., Freeska I., Meretey K. Serum IgE levels and IgE immune complexes in patients with atopic dermatitis. Dermatol Monatsschr 1988; 174: 671-673.
17. Capron A., Dessaint J. P. A role for IgE in protective immunity. IRCS J Med Sci 1975; 3: 477-481.
18. Johansson S. G. O. Raised levels of a new immunoglobulin class (IgND) in asthma. Lancet 1967; 2: 951-953.
19. Johansson S. G. O., Bennich H., Berg T., Hogman C. Some factors influencing the serum IgE levels in atopic diseases. Clin Exp Immunol 1970; 6: 43-47.
20. Johansson S. G., Meibin T., Vahlquist B. Immunoglobulin levels in Ethiopian pre-school children with special reference to high concentrations of immunoglobin E (IgND). Lancet 1968; 1: 1117-1118.
21. Hogarth-Scott R. C., Johansson S. G., Bennich H. Antibodies to Toxocara in the sera of visceral larva migrans patients significance of raised levels of IgE. Clin Exp Immunol 1969; 5: 619-625.
22. Rosenberg E. B., Polmar S. H., Whalen G. E. Increased circulating IgE in trichinosis. Ann Intern Med 1971; 75: 575-578.
23. Thompson C. IgE declares war on parasites. Lancet 1994; 343: 309-310.
24. Butterworth A. E., Dunne D. W., Fulford A. J. C., Thorne K. J. I., Gachuhi K., Ouma J. H., Sturrock R. F. Human immunity to Schistosoma mansoni: Observations on mechanisms, and implications for control. Immunol Invest 1992; 21: 391-407.
25. Hagan P. IgE and protective immunity to helminth infections. Parasite Immunol 1993; 15: 1-4.
26. Grove D. I., Forbes I. J. Increased resistance to helminth infestation in an atopic population. Med J Aust 1975; 1: 336-338.
27. Dunne D. W., Webster M., Smith P., Langley J. G., Richardson B. A., Fulford A. J., Butterworth A. E., Sturrock R. F., Kariuki H. C., Ouma J. H. The isolation of a 22 kDa band after SDS-PAGE of Schistosoma mansoni adult worms and its use to demonstrate that IgE responses against the antigen(s) it contains are associated with human resistance to reinfection. Parasite Immunol 1997; 19: 79-89.
28. Bloch E. F., Malveaux F. J. The significance of immunoglobulin E in resistance to parasitic infections. Ann Allergy 1985; 54: 83-93.
29. King C. L., Jia X. L., Malhorta I., Liu S. F., Mahmoud A. F., Oettgen H. C. Mice with a targeted deletion of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with Schistosoma mansoni. J Immunol 1997; 158: 294-300.
30. Kigoni E. P., Elsas P. P. X., Lenzi H. L., Dessein A. J. IgE antibody and resistance to infection II. Effect of IgE suppression on the early and late skin reaction and resistance of rats to Schistosoma mansoni infection. Eur J Immunol 1986; 16: 589-595.
31. Pritchard D. I. Immunity to helminths: Is too much IgE parasite - Rather than host protective? Parasite Immunol 1993; 15: 5-9.
32. Moqbel R., Pritchard D. I. Parasites and allergy: Evidence for a 'cause and effect' relationship. Clin Exp Allergy 1990; 20: 611-618.
33. Lynch N. R., Hagel I. A., Palenque M. E., DiPrisco M. C., Escudero J. E., Corao L. A., Sandia J. A., Ferreira L. J., Botto C., Perez M., LeSouef P. N. Relationship between helminthic infection and IgE response in atopic and nonatopic children in a tropical environment. J Allergy Clin Immunol 1998; 101: 217-221.
34. Shield J., Scrimgoeur E., Vaterlaws A. Intestinal helminths in an adult hospital population in the Eastern Highlands of Papua New Guinea: Relationship with anaemia, eosinophilia and asthma. PNG Med J 1980; 23: 157-164.
35. Masters S., Barrett-Connor E. Parasites and asthma: Predictive or protective? Epidemiol Rev 1985; 7: 49-57.
36. Khaled H. M. Bladder cancer and bilharziasis today. Cancer J 1993; 6: 65-71.
37. Dobson C., Yong W. K. Immunobiology of Aniostrongylus cantonensis and other aberrant forms. In: E. J. L. Soulsby (ed). Immune Responses in Parasitic Infections: Immunology, Immunopathology, and Immunoprophylaxis, vol. 1. Boca Raton: CRC Press, 1987.
38. Alcock P. A. Food Poisoning. London: H. K. Lewis and Co., 1983.
39. Mitchell G. F. Responses to infection with metazoan and protozoan parasites in mice. Adv Immunol 1979; 28: 451-511.
40. Ogilvie B. M., Jones V. E. Immunity in the parasitic relationship between helminths and hosts. Prog Allergy 1973; 17: 93-144.
41. Lemmer L. B., Fripp P. J. Schistosomiasis and malignancy. S Afr Med J 1994; 84: 211-215.
42. Fawzi R. N. Carcinoma of the bladder in Egypt. In: Proceedings of the 7th International Cancer Congress. London: Urine International Control Concern, 1958: 57.
43. Pfister E. Uber den endemischen Blasenkrebs bei Bilarziasis. Z Urol 1921; 15: 51-57.
44. Shamma A. H. Schistosomiasis and cancer in Iraq. Am J Clin Pathol 1955; 25: 1283-1284.
45. El Bolkainy M. N., Ghoneim M. A., Mansour M. A. Carcinoma of the bilharzial bladder in Egypt: Clinical and pathological features. Br J Urol 1972; 44: 561-570.
46. Aboul Nasr A. L., Gazayerli M. E., Fawzi R. M., El-Sebai I. Epidemiology and pathology of cancer of the bladder in Egypt. Acta Unio Internationalis Contra Cancrum 1962; 18: 528-537.
47. Lucas S. B. Bladder tumours in Malawi. Br J Urol 1982; 54: 275-279.
48. Elem B., Purohit R. Carcinoma of the urinary bladder in Zambia. A quantitative estimation of Schistosoma haematobium infection. Br J Urol 1983; 55: 275-278.
49. El Bolkainy M. N., Mokhtar N. M., Ghoneim M. A., Hussein M. H. Impact of schistosomiasis on the pathology of bladder carcinoma. Cancer 1981; 48: 2643-2648.
50. Malik M. O. A., Veress B., Daoud E. H., El-Hassan A. M. Pattern of bladder cancer in the Sudan and its relation to schistosomiasis: A study of 255 vesical carcinomas. J Trop Med Hyg 1975; 78: 219-223.
51. Chen M. C., Chuang C. Y., Chang P. Y., Hu J. C. Evolution of colorectal cancer in schistosomiasis: Transitional mucosal changes adjacent to large intestinal carcinoma in colectomy specimens. Cancer 1980; 46: 1661-1675.
52. Xu Z., Su D. L. Schistosoma japonicum and colorectal cancer: An epidemiological study in the People's Republic of China. Int J Cancer 1984; 34: 315-318.
53. Shindo K. Significance of Schistosoma japonicum in the development of cancer of the large intestine: Report of a case and review of the literature. Dis Colon Rectum 1976; 19: 460-469.
54. Takemura Y., Kikuchi S., Inaba Y. Epidemiologic study of the relationship between schistosomiasis due to Schistosoma japonicum and liver cancer/cirrhosis. Am J Trop Med Hyg 1998; 59: 551-556.
55. Ferguson A. Associated bilarziasis and primary malignant disease of the urinary bladder with observations on a series of forty cases. J Pathol Bacteriol 1911; 16: 76-94.
56. El-Sebai I. End results of treatment of cancer in the bilharzial bladder, prognosis, recurrences, and rehabilitation. In: I. El-Sebai (ed). Bladder Cancer, vol. II. Boca Raton: CRC Press, 1983: 163-197.
57. Nakashima T., Okuda K., Kojiro M., Sakamoto K., Kubo Y., Shimokana Y. Primary liver cancer coincident with Schistosoma japonicum. A study of 24 necropsies. Cancer 1975; 36: 1483-1489.
58. Varner A. E. The cyclooxygenase-2 theory of atopy and asthma. Pediatr Asthma Allergy Immunol 1999; 13: 43-50.
59. H2-type cytokines of the arachidonic-acid metabolic pathway in human alveolar macrophages and monocytes. Am J Respir Cell Mol Biol 1998; 19: 300-307.